TURBO BEAR OPEN END - RECORDATI INDUSTRIA CHIMICA E FARMA | Market Closed - Borsa Italiana 14:33:07 2024-05-13 EDT | ||
| 1.051 EUR | +3.55% |
|
| Current month | -5.18% | ||
| 1 month | -10.08% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-13 | 1.051 | +3.55% | 69 |
| 24-05-10 | 1.015 | -3.43% | 110 |
| 24-05-09 | 1.051 | +7.46% | 96 |
| 24-05-08 | 0.978 | -10.19% | 99 |
| 24-05-07 | 1.089 | +4.11% | 80 |
Real-time Borsa Italiana
Last update May 13, 2024 at 02:33 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | RECORDATI |
| Issuer | 
UniCredit
|
| UD2BYE | |
| ISIN | DE000HD2BYE3 |
| Date issued | 2024-01-31 |
| Strike | 57.98 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.239 € |
|---|---|
| Lowest since issue | 0.796 € |
| Spread | 0.082 € |
| Spread % | 7.51% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
50.8
EUR
Average target price
52.24
EUR
Spread / Average Target
+2.83%
- Stock Market
- Certificates
- UD2BYE Certificat